Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor

by Nicola Sgherza, Paola Curci, Rita Rizzi, Rita Rizzi, Pellegrino Musto, Pellegrino Musto
Published 2021-09-01

What Is New in the Treatment of Smoldering Multiple Myeloma?

by Niccolo’ Bolli, Nicola Sgherza, Paola Curci, Rita Rizzi, Vanda Strafella, Mario Delia, Vito Pier Gagliardi, Antonino Neri, Luca Baldini, Francesco Albano, Pellegrino Musto
Published 2021-01-01

Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas

by Francesco Gaudio, Annamaria Giordano, Vincenzo Pavone, Tommasina Perrone, Paola Curci, Domenico Pastore, Mario Delia, Clara de' Risi, Alessandro Spina, Vincenzo Liso, Giorgina Specchia
Published 2011-01-01

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

by Giacomina Brunetti, Rita Rizzi, Giuseppina Storlino, Sara Bortolotti, Graziana Colaianni, Lorenzo Sanesi, Luciana Lippo, Maria Felicia Faienza, Anna Mestice, Paola Curci, Giorgina Specchia, Maria Grano, Silvia Colucci
Published 2018-10-01